TEX46 and prostate cancer: Miyazaki et al. found that TEX from EBAG9-overexpressing prostate cancer cells has the potential to facilitate the immune escape of tumors by inhibiting T-cell cytotoxicity and modulating immune-related gene expression in T cells [162].